Literature DB >> 27817945

Respiratory motion-management in stereotactic body radiation therapy for lung cancer - A dosimetric comparison in an anthropomorphic lung phantom (LuCa).

Stefanie Ehrbar1, Rosalind Perrin2, Marta Peroni2, Kinga Bernatowicz2, Thomas Parkel3, Izabela Pytko4, Stephan Klöck4, Matthias Guckenberger4, Stephanie Tanadini-Lang4, Damien Charles Weber5, Antony Lomax6.   

Abstract

BACKGROUND AND
PURPOSE: The objective of this study was to compare the latest respiratory motion-management strategies, namely the internal-target-volume (ITV) concept, the mid-ventilation (MidV) principle, respiratory gating and dynamic couch tracking.
MATERIALS AND METHODS: An anthropomorphic, deformable and dynamic lung phantom was used for the dosimetric validation of these techniques. Stereotactic treatments were adapted to match the techniques and five distinct respiration patterns, and delivered to the phantom while radiographic film measurements were taken inside the tumor. To report on tumor coverage, these dose distributions were used to calculate mean doses (Dmean), changes in homogeneity indices (ΔH2-98), gamma agreement, and areas covered by the planned minimum dose (A>Dmin).
RESULTS: All techniques achieved good tumor coverage (A>Dmin>99.0%) and minor changes in Dmean (±3.2%). Gating and tracking strategies showed superior results in gamma agreement and ΔH2-98 compared to ITV and MidV concepts, which seem to be more influenced by the interplay and the gradient effect. For lung, heart and spinal cord, significant dose differences between the four techniques were found (p<0.05), with lowest doses for gating and tracking strategies.
CONCLUSION: Active motion-management techniques, such as gating or tracking, showed superior tumor dose coverage and better organ dose sparing than the passive techniques based on tumor margins. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Couch tracking; Lung phantom; Radiotherapy; Respiratory motion management; Stereotactic body radiation therapy

Mesh:

Year:  2016        PMID: 27817945     DOI: 10.1016/j.radonc.2016.10.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

1.  Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy.

Authors:  Jan Unkelbach; Dávid Papp; Melissa R Gaddy; Nicolaus Andratschke; Theodore Hong; Matthias Guckenberger
Journal:  Radiother Oncol       Date:  2017-09-23       Impact factor: 6.280

Review 2.  Image guidance in proton therapy for lung cancer.

Authors:  Miao Zhang; Wei Zou; Boon-Keng Kevin Teo
Journal:  Transl Lung Cancer Res       Date:  2018-04

3.  Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.

Authors:  Hirotaka Hasegawa; Masahiro Shin; Ryoko Niwa; Satoshi Koizumi; Shoko Yoshimoto; Naoyuki Shono; Yuki Shinya; Hirokazu Takami; Shota Tanaka; Motoyuki Umekawa; Shiori Amemiya; Taichi Kin; Nobuhito Saito
Journal:  J Neurooncol       Date:  2022-07-26       Impact factor: 4.506

4.  Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.

Authors:  Jie Shan; Yunze Yang; Steven E Schild; Thomas B Daniels; William W Wong; Mirek Fatyga; Martin Bues; Terence T Sio; Wei Liu
Journal:  Med Phys       Date:  2020-10-13       Impact factor: 4.071

5.  Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part I: Intra-fraction breathing motion management.

Authors:  Gail Anastasi; Jenny Bertholet; Per Poulsen; Toon Roggen; Cristina Garibaldi; Nina Tilly; Jeremy T Booth; Uwe Oelfke; Ben Heijmen; Marianne C Aznar
Journal:  Radiother Oncol       Date:  2020-06-23       Impact factor: 6.280

Review 6.  Radiotherapy for Oligometastatic Lung Cancer.

Authors:  Derek P Bergsma; Joseph K Salama; Deepinder P Singh; Steven J Chmura; Michael T Milano
Journal:  Front Oncol       Date:  2017-09-19       Impact factor: 6.244

7.  Comparative analysis for renal stereotactic body radiotherapy using Cyberknife, VMAT and proton therapy based treatment planning.

Authors:  Atallah Baydoun; Neha Vapiwala; Lee E Ponsky; Musaddiq Awan; Ali Kassaee; David Sutton; Tarun K Podder; Yuxia Zhang; Donald Dobbins; Raymond F Muzic; Bryan Traughber; Mitchell Machtay; Rodney Ellis
Journal:  J Appl Clin Med Phys       Date:  2018-03-14       Impact factor: 2.102

8.  Accuracy of real-time respiratory motion tracking and time delay of gating radiotherapy based on optical surface imaging technique.

Authors:  Li Chen; Sen Bai; Guangjun Li; Zhibin Li; Qing Xiao; Long Bai; Changhu Li; Lixun Xian; Zhenyao Hu; Guyu Dai; Guangyu Wang
Journal:  Radiat Oncol       Date:  2020-07-10       Impact factor: 3.481

9.  Differences in Expression of Mitochondrial Complexes Due to Genetic Variants May Alter Sensitivity to Radiation-Induced Cardiac Dysfunction.

Authors:  Rachel A Schlaak; Anne Frei; Gopika SenthilKumar; Shirng-Wern Tsaih; Clive Wells; Jyotsna Mishra; Michael J Flister; Amadou K S Camara; Carmen Bergom
Journal:  Front Cardiovasc Med       Date:  2020-03-05

Review 10.  The Role of Mitochondrial Dysfunction in Radiation-Induced Heart Disease: From Bench to Bedside.

Authors:  Katie Livingston; Rachel A Schlaak; Lindsay L Puckett; Carmen Bergom
Journal:  Front Cardiovasc Med       Date:  2020-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.